Hematopoietic Stem Cell Transplantation
Medicine & Life Sciences
60%
Multiple Myeloma
Medicine & Life Sciences
45%
Stem Cell Transplantation
Medicine & Life Sciences
40%
T-Cell Lymphoma
Medicine & Life Sciences
35%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Medicine & Life Sciences
29%
Registries
Medicine & Life Sciences
28%
AIC246
Medicine & Life Sciences
28%
Inotuzumab Ozogamicin
Medicine & Life Sciences
28%
Cheng, C. N. ,
Li, S. S. ,
Yeh, Y. H. ,
Shen, C. F. &
Chen, J. S. ,
2022 4月 ,
於: Journal of Microbiology, Immunology and Infection. 55 ,
2 ,
p. 323-327 5 p. 研究成果: Article › 同行評審
AIC246
100%
Hematopoietic Stem Cell Transplantation
56%
Cytomegalovirus
52%
Allogeneic Cells
19%
Stem Cell Transplantation
18%
Cheng, C. N. ,
Li, S. S. ,
Hsu, Y. T. ,
Chen, Y. P. ,
Chen, T. Y. &
Chen, J. S. ,
2022 3月 ,
於: Journal of the Formosan Medical Association. 121 ,
3 ,
p. 694-702 9 p. 研究成果: Article › 同行評審
Precursor Cell Lymphoblastic Leukemia-Lymphoma
100%
Young Adult
82%
Drug Therapy
59%
Hematopoietic Stem Cell Transplantation
43%
Residual Neoplasm
32%
Suzuki, K. ,
Min, C. K. ,
Kim, K. ,
Lee, J. J. ,
Shibayama, H. ,
Ko, P. S. ,
Huang, S. Y. ,
Li, S. S. ,
Ding, B. ,
Khurana, M. &
Iida, S. ,
2021 12月 ,
於: International Journal of Hematology. 114 ,
6 ,
p. 653-663 11 p. 研究成果: Article › 同行評審
daratumumab
100%
carfilzomib
93%
Multiple Myeloma
58%
Dexamethasone
54%
Risk Assessment
6%
Chien, S. H. ,
Yao, M. ,
Li, C. C. ,
Chang, P. Y. ,
Yu, M. S. ,
Huang, C. E. ,
Tan, T. D. ,
Lin, C. H. ,
Yeh, S. P. ,
Li, S. S. ,
Wang, P. N. ,
Liu, Y. C. &
Gau, J. P. ,
2021 12月 ,
於: Journal of the Formosan Medical Association. 120 ,
12 ,
p. 2144-2152 9 p. 研究成果: Article › 同行評審
GATA2 Deficiency
100%
Hematopoietic Stem Cell Transplantation
76%
Comorbidity
56%
Elderly
48%
Survival
22%
Taiwan Blood and Marrow Transplantation Registry (TBMTR) ,
2021 7月 ,
於: Bone Marrow Transplantation. 56 ,
7 ,
p. 1750-1753 4 p. 研究成果: Letter › 同行評審